Von Willebrand Disease — Research Summary
Printed from RareWays (rareways.com.au) on 27 July 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Are electrical stimulation devices the way forward for addressing heavy menstrual bleeding in women with von Willebrand disease?
Baldwin Maureen K — Expert review of hematology (3 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42398001/
- 2.
Bone Mineral Density in Hemophilia and VWD.
Battafarano Giulia et al. — Blood advances (2 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42392176/
- 3.
Exploratory Claims-Based Assessment of Diagnosed and Potentially Undiagnosed von Willebrand Disease in Japan.
Nagao Azusa et al. — Haemophilia : the official journal of the World Federation of Hemophilia (2 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42390756/
- 4.
Use of an Oral Health-Related Quality of Life Instrument to Measure Unmet Dental Care Needs in Adults With Inherited Bleeding Disorders.
Escobar Miguel A et al. — Haemophilia : the official journal of the World Federation of Hemophilia (2 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42390019/
- 5.
Molecular pathogenesis of coexisting type 1 von Willebrand disease caused by gene conversion and severe hemophilia a with F8 intron 22 inversion in a Chinese patient.
Wei Ziyan et al. — Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (1 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42144917/
Clinical Trials — Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Recruiting — Phase 1 — Hemab ApS
https://clinicaltrials.gov/study/NCT06754852
- 2.
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Recruiting — Hemab ApS
https://clinicaltrials.gov/study/NCT06610201
- 3.
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Recruiting — Phase 1 — Vega Therapeutics, Inc
https://clinicaltrials.gov/study/NCT05776069
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Von Willebrand Disease
Von Willebrand Disease is the most common inherited bleeding disorder, caused by a deficiency or dysfunction of von Willebrand factor — a protein essential for blood clotting. It affects approximately 1% of the global population, though most cases are mild. Symptoms include easy bruising, prolonged bleeding from cuts, and heavy menstrual periods.
Most Recent Research
Common Questions
What is Von Willebrand Disease?
Von Willebrand Disease is the most common inherited bleeding disorder, caused by a deficiency or dysfunction of von Willebrand factor — a protein essential for blood clotting. It affects approximately 1% of the global population, though most cases are mild. Symptoms include easy bruising, prolonged bleeding from cuts, and heavy menstrual periods.
How many clinical trials are available for Von Willebrand Disease?
RareWays currently indexes 87 clinical trials for Von Willebrand Disease, of which 25 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Von Willebrand Disease come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Von Willebrand Disease.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.